Skip to content
Screener

Enovis ENOV Reconstructive — Other Cost and Expense, Operating

Other segment segments

Prevention & Recovery
$111.25M

Similar metrics at other companies

World Kinect logo
WKCLand — Other Cost and Expense, Operating
$4.3M+13.2%
LAD
LADFinancing Operations — Other Cost and Expense, Operating
$14.5M+13.3%
World Kinect logo
WKCAviation — Other Cost and Expense, Operating
$12.3M+28.1%
Kinder Morgan logo
KMITerminals — Other Cost and Expense, Operating
$141M+3.7%
World Kinect logo
WKCMarine — Other Cost and Expense, Operating
$6.8M+28.3%
Labcorp Holdings logo
LHDiagnostics — Other Cost and Expense, Operating
$438M+1.8%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.53B-5.5%
Enterprise value$2.83B-4.9%
P/S0.7×-0.1×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:OtherCostAndExpenseOperating.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemThree Months Ended / July 3, 2026Three Months Ended / July 4, 2025Six Months Ended / July 3, 2026Six Months Ended / July 4, 2025
Net sales$294,534$273,975$611,667$560,225
Segment cost of sales98,87397,750196,208195,024
Segment research and development23,98021,03147,76640,318
Segment operating expense141,376134,729290,659273,666
Total segment expenses264,229253,510534,633509,008
Add: Depreciation23,68923,95749,41849,354
Adjusted EBITDA (non-GAAP)(1)$53,994$44,422$126,452$100,571
Total:

Item 1. Financial Statements

FAQ

What is Enovis's reconstructive — other cost and expense, operating?
Enovis (ENOV) reported reconstructive — other cost and expense, operating of $141.38M in Q2 2026.
How has Enovis's reconstructive — other cost and expense, operating changed year-over-year?
Enovis's reconstructive — other cost and expense, operating increased by 4.9% year-over-year, from $134.73M to $141.38M.
What is the long-term trend for Enovis's reconstructive — other cost and expense, operating?
Over 3 years (2022 to 2025), Enovis's reconstructive — other cost and expense, operating has grown at a 21.9% compound annual growth rate (CAGR), from $294.05M to $532.53M.
What does reconstructive — other cost and expense, operating mean?
Operating expenses incurred by the reconstructive segment that are not classified as direct production costs or research and development, such as administrative overhead or marketing expenses. This metric helps in understanding the underlying cost structure and operational leverage of the segment.

Ask your AI about Enovis's reconstructive — other cost and expense, operating.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude